BREITENSTEIN; Werner

Patent Applications and Registrations

Patent applications and USPTO patent grants for BREITENSTEIN; Werner.The latest application filed is for "small molecule lfa-1 inhibitors".

Company Profile

1.22.26

BREITENSTEIN; Werner - Basel CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Small Molecule Lfa-1 Inhibitors App 20190040008 - BREITENSTEIN; Werner ; et al.	2019-02-07
Small molecule LFA-1 inhibitors Grant 10,077,238 - Breitenstein , et al. September 18, 2	2018-09-18
Small Molecule Lfa-1 Inhibitors App 20170121284 - BREITENSTEIN; Werner ; et al.	2017-05-04
Compounds and compositions as protein kinase inhibitors Grant 8,552,002 - Ding , et al. October 8, 2	2013-10-08
4-phenylpiperidine derivatives as renin inhibitors Grant 8,362,040 - Sedrani , et al. January 29, 2	2013-01-29
Compounds And Compositions As Protein Kinase Inhibitors App 20130012704 - DING; Qiang ; et al.	2013-01-10
Compounds And Compositions As Protein Kinase Inhibitors App 20130012476 - DING; Qiang ; et al.	2013-01-10
Compounds and compositions as c-kit and PDGFR kinase inhibitors Grant 8,338,417 - Li , et al. December 25, 2	2012-12-25
Organic compounds Grant 8,178,559 - Breitenstein , et al. May 15, 2	2012-05-15
Organic compounds Grant 8,163,773 - Breitenstein , et al. April 24, 2	2012-04-24
Organic compounds Grant 8,084,450 - Breitenstein , et al. December 27, 2	2011-12-27
Organic Compounds App 20110263560 - BREITENSTEIN; Werner ; et al.	2011-10-27
Arylsulfonamido-substituted hydroxamic acid derivatives Grant 8,034,810 - Breitenstein , et al. October 11, 2	2011-10-11
Inhibitors Of Tyrosine Kinases App 20110218187 - BREITENSTEIN; Werner ; et al.	2011-09-08
Inhibitors of tyrosine kinases Grant 7,956,053 - Breitenstein , et al. June 7, 2	2011-06-07
4-Phenylpiperidine Derivatives as Renin Inhibitors App 20100240679 - Sedrani; Richard ; et al.	2010-09-23
Compounds And Compositions As C-kit And Pdgfr Kinase Inhibitors App 20100234406 - Li; Xiaolin ; et al.	2010-09-16
4-phenylpiperidine derivatives as renin inhibitors Grant 7,754,727 - Sedrani , et al. July 13, 2	2010-07-13
Pyrrolidine Derivatives For The Treatment Of A Disease Depending On The Activity Of Renin App 20100087427 - Breitenstein; Werner ; et al.	2010-04-08
Compounds And Compositions As Protein Kinase Inhibitors App 20100048539 - Chianelli; Donatella ; et al.	2010-02-25
Lck inhibitors App 20100029636 - Buehlmayer; Peter ; et al.	2010-02-04
Pyrimidineamide derivatives and the use thereof Grant 7,655,669 - Manley , et al. February 2, 2	2010-02-02
Organic Compounds App 20090312304 - Breitenstein; Werner ; et al.	2009-12-17
Inhibitors Of Tyrosine Kinases App 20090286821 - Breitenstein; Werner ; et al.	2009-11-19
Organic Compounds App 20090233920 - Breitenstein; Werner ; et al.	2009-09-17
Inhibitors of tyrosine kinases Grant 7,569,566 - Breitenstein , et al. August 4, 2	2009-08-04
Compounds and Compositions as Protein Kinase Inhibitors App 20090137804 - Ding; Qiang ; et al.	2009-05-28
Arylsulfonamido-substituted hydroxamic acid derivatives App 20080275127 - Breitenstein; Werner ; et al.	2008-11-06
4-Phenylpiperidine Derivatives as Renin Inhibitors App 20080269255 - Sedrani; Richard ; et al.	2008-10-30
3-Mono-and 3,5-Disubstituted Piperidine Derivatives as Renin Inhibitors App 20080194629 - Baeschlin; Daniel Kaspar ; et al.	2008-08-14
Inhibitors Of Tyrosine Kinases App 20080188451 - Breitenstein; Werner ; et al.	2008-08-07
N-phenyl-3-pyrimidine-amine derivatives Grant 7,329,661 - Buerger , et al. February 12, 2	2008-02-12
N-phenyl-2-pyrimidine-amine derivatives Grant 7,312,216 - Buerger , et al. December 25, 2	2007-12-25
N-phenyl-2-pyrimidine-amine Derivatives App 20070265292 - Buerger; Hans Michael ; et al.	2007-11-15
Inhibitors of tyrosine kinases App 20070093506 - Breitenstein; Werner ; et al.	2007-04-26
4-Phenylpiperidine derivatives as renin inhibitors App 20070078164 - Sedrani; Richard ; et al.	2007-04-05
Inhibitors of tyrosine kinases Grant 7,169,791 - Breitenstein , et al. January 30, 2	2007-01-30
Arylsulfonamido-substituted hydroxamic acid derivatives Grant 7,138,432 - Breitenstein , et al. November 21, 2	2006-11-21
N-phenyl-2-pyrimidine-amine derivatives App 20060223818 - Buerger; Hans Michael ; et al.	2006-10-05
Inhibitors of tyrosine kinases App 20060167015 - Breitenstein; Werner ; et al.	2006-07-27
N-phenyl-2-pyrimidine-amine derivatives Grant 7,081,532 - Buerger , et al. July 25, 2	2006-07-25
Novel pyrimidineamide derivatives and the use thereof App 20060142577 - Manley; Paul William ; et al.	2006-06-29
N-phenyl-2-pyrimidine-amine derivatives App 20040102453 - Buerger, Hans Michael ; et al.	2004-05-27
Process for the preparation of dimethylmaleic anhydride Grant 4,644,069 - Baumann , et al. February 17, 1	1987-02-17
Heterocyclicamino containing benzofurans and 2,3-dihydrobenzofurans, compositions and use Grant 4,558,043 - Wenk , et al. December 10, 1	1985-12-10
Benzofuran-2(3H)-ones used as anti-inflammatory agents Grant 4,514,415 - Wenk , et al. April 30, 1	1985-04-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.